TERT and cancer: Plk1 interacts directly with TERT, independently of its kinase activity, and enhances the stability of TERT by inhibiting its ubiquitin-mediated degradation by MKRN1 and HDM2, thereby increasing cancer cell telomerase activity [97, 98].